ACELYRIN, INC. Rings the Nasdaq Stock Market Opening Bell

ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company creating an industry-leading immunology portfolio, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Shao-Lee Lin, M.D., Ph.D., Founder and Chief Executive Officer, rings the Opening Bell.